# Inmune Bio, Inc.: Form 8-K, filed Jul 1, 2026

- Company: [Inmune Bio, Inc.](/companies/inmb.md) (CIK 1711754)
- Form: 8-K
- Filed: 2026-07-01
- Accepted by EDGAR: Jul 1, 2026, 07:16 ET
- Period: 2026-06-30
- Accession: 0001213900-26-073983
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/ea0296624-8k_inmune.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1711754/000121390026073983/ea0296624-8k_inmune.htm

Filed Jul 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-073983. Last ingested by Listed: Nov 5, 2026, 16:25 ET. No prices; not investment advice.